Advertisement

April 13, 2022

Corindus Establishes New, Expanded Headquarters in United States

April 13, 2022—Corindus, a Siemens Healthineers Company, announced the opening of its new headquarters at 275 Grove Street in Newton, Massachusetts. The headquarters will serve as the global Center of Excellence for Siemens Healthineers’ endovascular robotic technologies that encompasses development, manufacturing, and administration activities.

Siemens Healthineers relocated the Corindus headquarters from its previous location in Waltham, Massachusetts, doubling the size from 35,000 square feet to 77,000 square feet at its new location.

According to Corindus, the larger Newton facility is a modern, flexible workspace built to accommodate workforce growth and respond to employee desires in a new, collaborative work environment. The new facility marks the first of 15 new offices or major facility expansions that Siemens Healthineers plans in the United States.

The space features a fully equipped “Customer Experience Center” that simulates the robotic setup in a hospital catheterization lab and control room that will include remote capabilities over various types of connections. The new office will provide physicians and catheterization lab personnel the opportunity to participate in interactive demonstrations of the company's CorPath GRX system and future innovations.

Corindus’ CorPath GRX system is FDA-cleared to bring robotic precision to percutaneous coronary and vascular procedures and has CE Mark approval for neurovascular use in select markets. The robotic system is equipped to improve treatment modalities in coronary, peripheral, and neurovascular disease, stated the company.

Per Bergman, Vice President of Research and Development at Corindus, commented in the company’s press release, “The significantly larger lab space and the additional investments in equipment and technology will aid in the development process of our devices. The larger dedicated lab for research and development activities will enable our innovation teams to more effectively collaborate and scale our technology. Our new state-of-the-art cleanroom and a model shop will allow for quicker prototype machining and reduced development timelines.”

Advertisement


April 13, 2022

FDA Issues Draft Guidance for Industry to Increase Racial and Ethnic Diversity in Clinical Trials

April 12, 2022

Transit Scientific’s XO Cross Support Catheter Platform Receives FDA Clearance for Coronary Use